Ritalin LA Prolonged Release Capsules 40mg
- Name:
Ritalin LA Prolonged Release Capsules 40mg
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 03/12/20

Click on this link to Download PDF directly
Novartis Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 3 December 2020 SPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 3 December 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 2 December 2019 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 2 December 2019 PIL
Reasons for updating
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 4 - possible side effects
Updated on 26 November 2019 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 22 January 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 24 July 2018 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 29 May 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 10 May 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 15 March 2018 SPC
Reasons for updating
- Change to section 4.9 - Overdose
- Change to section 6.4 - Special precautions for storage
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 15 March 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 21 July 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 21 July 2017 PIL
Reasons for updating
- Change to section 4 - possible side effects
Updated on 11 May 2017 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 29 June 2015 SPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 30 April 2015 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Addition of information on reporting a side effect.
Updated on 29 April 2015 PIL
Reasons for updating
- Change to, or new use for medicine
Updated on 10 April 2015 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
-
Section 4.8 (Undesirable effects): The adverse reaction(s) of logorrhea should be added under the SOC psychiatric disorders with a frequency unknown
Updated on 27 June 2013 PIL
Reasons for updating
- Improved electronic presentation
Updated on 5 September 2012 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to improve clarity and readability
Updated on 29 August 2012 SPC
Reasons for updating
- New individual SPC (was previously included in combined SPC)
- Individual presentations superseded by joint SPC
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 1 August 2012 PIL
Reasons for updating
- Improved electronic presentation
Updated on 29 July 2011 PIL
Reasons for updating
- Change to date of revision
- PIL retired pending re-submission
Updated on 27 June 2006 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to side-effects
- Change to date of revision
Updated on 27 August 2004 PIL
Reasons for updating
- New PIL for medicines.ie